| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
InnovAge Holding Corp. Common Stock
$10.94
+0.02 (+0.18%)
Market Cap
1.48 B
EPS
-0.09
P/E Ratio
-
Value Trade
2.35 M
-0.18 %
Week
-4.88 %
1 Month
46.97 %
3 Month
22.7 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
2.89 K
52 Week Range
3.54 - 12.64
% held by Insiders
84.7 %
% held by Institutions
13.63 %
Enterprise Value
1.40 B
Total Shares
135.74 M
Short %
3.89 %
Float Shares
21.08 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
INNV Clinical Trial Results & History
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in INNV
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
INNV Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-INNV
Aug 26, 2026▲ +0.2%today
InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference
InnovAge Holding Corp. will announce its fiscal fourth quarter and full year financial results on September 8, 2026. A conference call will follow at 5 p.m. E.T. Additionally, the company will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 8:00 AM E.T., with live webcasts available for both events.
Read more →-INNV
May 12, 2026InnovAge Appoints Jennifer Browne as President and Chief Operating Officer DENVER
InnovAge has appointed Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026. With extensive experience in value-based healthcare, Browne's leadership is expected to enhance InnovAge's performance and compliance. She will focus on operational execution, participant experience, and scaling services to reach more seniors. The appointment reflects InnovAge's commitment to sustainable growth and improving care for older adults.
Read more →-INNV
May 5, 2026INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2025 DENVER, CO.
InnovAge Holding Corp. reported financial results for the fiscal third quarter ending March 31, 2026, highlighting a 15.5% increase in total revenues to $251.9 million. Despite the revenue growth, the company faced a net loss of $29.9 million compared to a loss of $11.1 million in the same period last year. InnovAge is raising its fiscal 2026 revenue and Adjusted EBITDA guidance, reflecting confidence in future performance improvements driven by recent investments. The overall financial performance shows a mixture of growth in revenues and increased losses, indicating areas for potential concern.
Read more →-INNV
Feb 5, 2026Proven Senior Care Model Takes Center Stage at the Capitol
InnovAge Holding Corp. met with Colorado lawmakers to advocate for the PACE program, emphasizing its effectiveness in providing comprehensive care for seniors. Seniors shared their positive experiences, highlighting the program's role in maintaining independence and reducing hospitalizations. InnovAge leaders stressed the need for awareness and support for PACE amidst budget discussions.
Read more →-INNV
Feb 3, 2026INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2025 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fiscal second quarter ended December 31, 2025, reporting significant improvement in its operating performance. The company achieved total revenues of $239.7 million, up by 14.7% compared to the previous year, alongside a turnaround from a loss to a net income of $11.8 million. Adjusted EBITDA also saw substantial growth, reaching $22.2 million. InnovAge maintains its focus on ensuring sustainable growth and improving healthcare outcomes for its participants.
Read more →-INNV
Jan 29, 2026InnovAge Expands Board with Appointment of Two Directors
InnovAge Holding Corp. has expanded its Board of Directors by appointing Pavithra Mahesh and Sean Traynor. Both directors bring extensive experience and institutional knowledge, with Mahesh serving on the Quality and Compliance Committee and Traynor on the Compensation, Nominating and Governance Committee. This expansion aims to strengthen InnovAge's strategic direction and enhance its PACE model for senior care.
Read more →-INNV
Jan 21, 2026InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026
InnovAge Holding Corp. will release its fiscal second quarter 2026 financial results on February 3, 2026, after market close. A conference call will follow at 5 p.m. E.T. to discuss the results. The company focuses on providing comprehensive healthcare programs for frail seniors through its PACE model, emphasizing quality care and cost reduction.
Read more →-INNV
Dec 30, 2025InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
InnovAge Holding Corp. announced its participation in the 44th Annual J.P. Morgan Healthcare Conference, where CEO Patrick Blair will present on January 12, 2026. The event will be webcast live, allowing broader access to the company's insights and strategies. InnovAge focuses on providing comprehensive healthcare programs for frail seniors, emphasizing quality care and cost reduction.
Read more →-INNV
Nov 4, 2025INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025 DENVER, CO.
InnovAge Holding Corp. announced strong financial results for the first quarter of fiscal 2026, reporting total revenues of $236.1 million, a 15.1% increase from the same period last year. The company achieved net income of $7.7 million, reversing a net loss from the previous year. Adjusted EBITDA also showed significant growth, up to $17.6 million, reflecting improved operational efficiency. InnovAge continues to focus on expanding its services and enhancing care for frail seniors through its PACE program.
Read more →-INNV
Sep 9, 2025▲ +6%on this news
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2025 DENVER, CO.
InnovAge Holding Corp. reported its financial results for the fourth quarter and fiscal year ending June 30, 2025. The company achieved a total revenue of $853.7 million, reflecting an 11.8% increase from the previous year. However, it also reported a significant increase in net loss, rising to $35.3 million, compared to $23.2 million in the prior year. Looking forward, InnovAge issued guidance for fiscal year 2026, estimating expected census and revenue growth, although potential external factors may affect actual performance.
Read more →-INNV
Feb 4, 2025INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2024 DENVER, CO.
InnovAge Holding Corp. has announced its financial results for the fiscal second quarter ended December 31, 2024, revealing a total revenue of $209 million, which represents a 10.6% increase from the previous year. Despite this growth, the company reported a significant net loss of $13.5 million, a steep increase from $3.8 million a year earlier. The company's contribution margin improved, but the adjusted EBITDA decreased compared to the prior year. Overall, while revenue growth shows promise, the increased losses raise concerns regarding financial sustainability.
Read more →-INNV
Nov 5, 2024INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2024 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the first fiscal quarter ending September 30, 2024, reporting total revenues of $205.1 million, a notable increase from the previous year. The company achieved a 50.6% improvement in its loss before income taxes, which decreased to $5.3 million, and its adjusted EBITDA increased significantly to $6.5 million. However, InnovAge still experienced a net loss of $5.7 million, down from $11 million a year prior. The press release also highlighted increases in their participant census and encouraged investors to note upcoming financial guidance while acknowledging potential external uncertainties.
Read more →-INNV
Nov 4, 2024Document InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services DENVER
InnovAge has appointed Michael Scarbrough as the new President and Chief Operating Officer and Maria Lozzano as President of Pharmacy Services, effective November 4, 2024. Scarbrough's extensive experience in healthcare is expected to support InnovAge's strategic goals, while Lozzano's promotion is aimed at enhancing pharmacy operations and participant experiences. The transition follows the departure of former COO Christine Bent, who is thanked for her service.
Read more →-INNV
Sep 10, 2024INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2024 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fourth quarter and fiscal year ending June 30, 2024. The company reported a year-over-year revenue increase of approximately 11% to $763.9 million, while also improving its net loss to $23.2 million from $43.6 million in the prior year. As part of a commitment to operational excellence, InnovAge expressed confidence in its financial performance and outlined ambitious growth plans for the upcoming fiscal year. The company anticipates an increase in participant census and revenue in FY 2025, indicating a positive outlook.
Read more →-INNV
Jun 10, 2024INNOVAGE HOLDING CORP. ANNOUNCES $5.0
InnovAge Holding Corp. has announced a $5.0 million share repurchase program, approved by its Board of Directors. The initiative allows the company to buy back its common stock from the open market or through other designated means, depending on various conditions. InnovAge emphasizes a commitment to improving senior care while maintaining a strategic approach to shareholder value by repurchasing shares. The company currently serves around 6,820 participants across 20 centers.
Read more →-INNV
May 7, 2024INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2024 DENVER, CO.
InnovAge Holding Corp. reported its financial results for the fiscal third quarter ending March 31, 2024. The company achieved a revenue increase of approximately 11.9% year-over-year, reflecting ongoing operational improvements. Despite a continued net loss of $6.2 million, which has decreased from the prior year, the firm showcased growth in its participant census. Adjusted EBITDA dipped slightly, but their contribution margin rose significantly, indicating overall progress in their business model.
Read more →-INNV
Feb 6, 2024▼ -6%on this news
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2023 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fiscal second quarter ending December 31, 2023, highlighting a 12.8% increase in total revenues, reaching $188.9 million. The company reported a reduced net loss of $3.8 million, significantly improving from $10.5 million in the same quarter last year. Adjusted EBITDA also turned positive with an increase of $9.7 million. Despite these improvements, the company acknowledged the ongoing risks associated with potential variations in actual results compared to its financial guidance.
Read more →-INNV
Nov 7, 2023INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2023 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fiscal first quarter ending September 30, 2023, reporting total revenues of $182.5 million, marking a 6.6% increase compared to the previous year. Despite a net loss of $11.0 million, the company improved its loss margin and adjusted EBITDA, reflecting ongoing progress in its operations. The CEO expressed optimism about sustained momentum in the business model, which focuses on healthcare for seniors. InnovAge continues to manage a considerable amount of debt while enhancing its service offerings across multiple states.
Read more →-INNV
Sep 12, 2023INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2023 DENVER, CO.
InnovAge Holding Corp. announced its financial results for the fourth quarter and fiscal year ended June 30, 2023, reporting a total revenue of $688.1 million, a decrease from the previous year. The company experienced a larger net loss of $43.6 million compared to $8.0 million in 2022, leading to concerns about profitability. Despite these challenges, InnovAge expressed optimism about its growth strategy and the expansion of its Program of All-Inclusive Care for the Elderly (PACE). The company provided guidance for fiscal year 2024, anticipating an increase in participants and total revenue.
Read more →-INNV
Aug 14, 2023InnovAge Strengthens Board with Appointment of New Independent Director DENVER
InnovAge Holding Corp. has appointed Teresa Sparks as a new independent director on its Board, following the departure of Sean Traynor. Sparks brings extensive experience in financial services and healthcare, and her appointment is viewed positively by InnovAge's leadership as a strategic enhancement to the Board. The company remains committed to serving frail, dual-eligible seniors through its PACE program, aiming to improve the quality of care for this vulnerable population.
Read more →-INNV
Jul 5, 2023InnovAge Names Ben Adams as New Chief Financial Officer DENVER
InnovAge Holding Corp. has appointed Ben Adams as its new Chief Financial Officer, effective July 10, 2023. He will lead the company's finance organization, taking over from Barb Gutierrez, who is leaving to pursue other opportunities. Adams has over 25 years of experience in healthcare finance, with previous roles as CFO at Kepro and RxSense. The InnovAge team expects his leadership will contribute to improving operational performance and expanding business capabilities in providing care for seniors.
Read more →-INNV
May 9, 2023INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2023 DENVER, CO.
InnovAge Holding Corp. announced its fiscal third quarter financial results for the period ending March 31, 2023. The company reported a total revenue of $172.5 million, marking a 2.7% decrease from $177.4 million in the same quarter of the previous year. While the center-level contribution margin showed a slight increase to $28.8 million, the company faced a net loss of $7.3 million, significantly higher than the net loss reported in the previous fiscal third quarter. Additionally, the company saw a decline in participant census, which raises concerns regarding its growth and revenue potential moving forward.
Read more →-INNV
May 1, 2023Final Sanction Removed at InnovAge Sacramento PACE Center Enabling New Participant Enrollment DENVER, CO.
InnovAge Holding Corp. has announced that the California Department of Health Care Services has lifted an enrollment sanction at its Sacramento PACE center, effective May 1, 2023. This decision follows a validation audit completed in December and a prior sanction release from the Centers for Medicare and Medicaid Services. With this change, InnovAge can resume enrolling eligible seniors into its PACE program while committing to corrective actions for continuous improvement in care quality.
Read more →-INNV
Mar 30, 2023▲ +6.4%on this news
InnovAge Diversifies Board of Directors with New Independent Director DENVER
InnovAge Holding Corp. has appointed Patty Fontneau as a new independent director on its Board, effective immediately. This change comes as two board members, Pavithra Mahesh and Caroline Dechert, have stepped down. Patty's vast experience in healthcare, especially in public health insurance and operations, is expected to enhance the board's effectiveness. InnovAge is committed to helping seniors maintain independence through its PACE program and believes Fontneau's leadership will support this mission.
Read more →-INNV
Mar 1, 2023InnovAge Names Christine Bent as Chief Operations Officer DENVER
InnovAge Holding Corp. has appointed Christine Bent as its Chief Operations Officer, effective March 20, 2023. Bent, who has significant experience in the healthcare sector, will manage operations at InnovAge's existing PACE centers and oversee new program developments. Patrick Blair, the CEO, emphasized her valuable experience and commitment to enhancing patient experiences. Bent's personal understanding of caregiving reinforces her dedication to serving seniors in their homes.
Read more →-INNV
Feb 7, 2023INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2022 DENVER, CO.
InnovAge Holding Corp. has announced its financial results for the fiscal second quarter ending December 31, 2022, reporting a net loss of $10,547,000 compared to a net income of $1,106,000 in the same period last year. Despite a dedicated operational foundation during sanctions, the company faced substantial financial challenges, including decreased revenues and margin declines. Future performance may be hindered by ongoing governmental audits and restrictions, particularly affecting their Sacramento center operations. The CEO expresses optimism about InnovAge's commitment to improving care for seniors going forward.
Read more →-INNV
Jan 23, 2023State and Federal Regulators Lift Sanctions at InnovAge's Colorado PACE Centers DENVER, CO.
InnovAge Holding Corp. announced the lifting of enrollment sanctions at its six Colorado PACE centers by CMS and HCPF, allowing the resumption of services for seniors. This follows previous sanctions lifted for its Sacramento center in California. While the company expresses optimism, it must conduct post-sanction corrective actions and is awaiting further developments in California. The CEO emphasized the dedication of their team and regulatory partners in enhancing care.
Read more →-INNV
Nov 22, 2022▲ +5.5%on this news
InnovAge Announces Release of CMS Sanction in Sacramento Center DENVER, CO.
InnovAge Announces Release of CMS Sanction in CO., November 22, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced today that the Centers for
Read more →-INNV
Nov 8, 2022INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2022 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2022 DENVER, CO., November 8, 2022 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, an
Read more →-INNV
Sep 13, 2022INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL YEAR AND FOURTH QUARTER ENDED JUNE 30, 2022 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL YEAR AND FOURTH QUARTER ENDED JUNE 30, 2022 DENVER, CO., September 13, 2022 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seni
Read more →-INNV
Jun 30, 2022▲ +13.5%on this news
InnovAge Appoints James Carlson to the Board as Non-Executive Chairman Denver
InnovAge Appoints James Carlson to the Board as Non-Executive Chairman Denver, June 30, 2022 - InnovAge (NASDAQ: INNV), today announced the appointment of experienced health care executive James ("Jim") Carlson to its Board of Directors, effective June 30, 2022. Carlson will s
Read more →-INNV
May 10, 2022▼ -9.6%on this news
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2022 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2022 DENVER, CO., May 10, 2022 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced
Read more →-INNV
Feb 9, 2022▲ +6.8%on this news
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2021 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2021 DENVER, CO., February 9, 2022 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, an
Read more →-INNV
Jan 3, 2022INNOVAGE
INNOVAGE ANNOUNCES THE RESIGNATION OF CEO MAUREEN THE APPOINTMENT OF PATRICK BLAIR AS PRESIDENT AND CEO January 3, 2022 - The Board of Directors of InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV) accepted the resignation of longtime CEO and director Maureen
Read more →-INNV
Dec 23, 2021▼ -35.6%on this news
InnovAge Announces Audit Sanctions In Colorado And Withdraws Guidance DENVER
InnovAge Announces Audit Sanctions In Colorado And Withdraws Guidance DENVER, December 23, 2021 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced t
Read more →-INNV
Nov 12, 2021▲ +5.8%on this news
InnovAge Appoints Patrick Blair as President DENVER
Appoints Patrick Blair as President November 12, 2021 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced today that its board of directors has appoin
Read more →-INNV
Nov 9, 2021INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2021 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2021 DENVER, CO., November 9, 2021 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, an
Read more →-INNV
Sep 21, 2021▼ -8.3%on this news· ran to -43% by day 3
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL YEAR AND FOURTH QUARTER ENDED JUNE 30, 2021 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL YEAR AND FOURTH QUARTER ENDED JUNE 30, 2021 DENVER, CO., September 21, 2021 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible senio
Read more →-INNV
May 10, 2021INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2021 DENVER, CO.
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL THIRD QUARTER ENDED MARCH 31, 2021 DENVER, CO., May 10, 2021 - InnovAge Holding Corp. (the "Company" or "InnovAge") (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced
Read more →-INNV
Mar 12, 2021InnovAge Announces Exercise of Underwriters' Option to Purchase Additional Shares DENVER, CO
InnovAge Announces Exercise of Underwriters' Option to Purchase Additional Shares DENVER, CO, March 12, 2021 - InnovAge Holding Corp. (InnovAge) today announced that on March 9, 2021, the underwriters of the previously announced initial public offering of 16,666,667 shares of
Read more →-INNV
Mar 3, 2021InnovAge Announces Pricing of Initial Public Offering DENVER, CO
InnovAge Announces Pricing of Initial Public Offering DENVER, CO, March 3, 2021 - InnovAge Holding Corp. (InnovAge) today announced the pricing of its initial public offering of 16,666,667 shares of its common stock at a price to the public of $21.00 per share. The shares are
Read more →Competitive Position
How INNV ranks across every disease it competes inCompetitive Position is a premium feature
See how INNV ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial